Phyxius Pharma's Acquisition

Phyxius Pharma was acquired by Oxygen Biotherapeutics on November 14, 2013.

Phyxius Pharma is a privately-held biopharmaceutical company focused on the development and near-term commercialization of levosimendan to prevent and treat cardiac surgery patients at risk for develo…

Articles about Phyxius Pharma's Acquisition: